K1K2Pu, a recombinant t-PA/u-PA Chimera with increased thrombolytic potency, consisting of amino acids 1 to 3 and 87 to 274 of human tissue-type plasminogen activator (t-PA) and amino acids 138 to 411 of human single chain urokinase-type plasminogen activator (scu-PA). Purification in centigram quantities and conditioning for use in man
- 1 February 1992
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 65 (3) , 421-438
- https://doi.org/10.1016/0049-3848(92)90172-7
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Coronary Thrombolysis: Streptokinase or Recombinant Tissue-Type Plasminogen Activator?Annals of Internal Medicine, 1990
- Production in Eukaryotic Cells and Characterization of Four Hybrids of Tissue-Type and Urokinase-Type Plasminogen ActivatorsDNA, 1989
- Innovative Approaches to Plasminogen Activator TherapyScience, 1989
- 112 Characterization of truncated SCU-PA derivativesFibrinolysis, 1988
- New strategies in the development of thrombolytic agentsAnnals of Hematology, 1988
- Catabolism of tissue-type plasminogen activator (t-PA), its variants, mutants and hybridsFibrinolysis, 1988
- Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction.Circulation, 1988
- Artificial exon shuffling between tissue-type plasminogen activator (t-PA) and urokinase (u-PA): a comparative study on the fibrinolytic properties of t-PA/u-PA hybrid proteinsBiochemistry, 1988
- Thrombolytic TherapyAnnual Review of Medicine, 1988
- Covalent molecular weight .apprx. 92,000 hybrid plasminogen activator derived from human plasmin amino-terminal and urokinase carboxyl-terminal domainsBiochemistry, 1986